J&J Vaccine Trial Pause Slows Market Advance

October 13, 2020

0

J&J Vaccine Trial Pause Slows Market Advance — *Image by NIAID*

Johnson & Johnson has 'paused', not halted, development of a vaccine for the Chinese coronavirus due to an illness of one of the participants in the trials.

“We’re letting safety protocol follow proper procedure here,” he said, adding that pauses in trials are “not uncommon," declared CEO Joseph Wolk on CNBC this morning.

“What it should also do is reassure the public that every scientific, medical and ethical standard is being applied here,” Wolk added.

“We must respect this participant’s privacy,” the company said in a statement late Monday. “We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information.”

Airlines stocks fell as a result.

Tech stocks rose again on positive news from Apple.

American banks reported strong earnings.

Consumer Price Index Core s.a. (Sep) printed at 296.26.

Consumer Price Index (MoM) (Sep) printed at the consensus estimate of 0.2%.

Consumer Price Index n.s.a. (MoM) (Sep) printed at 260.28 vs 260.348 estimate.

Consumer Price Index ex Food & Energy (MoM) (Sep) printed at the estimate of 0.2%.

Consumer Price Index (YoY) (Sep) printed at the estimate of 1.4%.

Consumer Price Index ex Food & Energy (MoM) (Sep) printed at 1.7% vs 1.8% estimate.

Author

CDM Staff

The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."